Frontier, Biotech

Frontier Biotech and GSK Enter Global Exclusive Licensing Agreement for Small Interfering RNA Therapeutics

Veröffentlicht: 17.03.2026 um 18:52 Uhr, prnewswire.co.uk

Frontier Biotechnologies Inc. New York China

/ dchen@frontierbiotech.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/frontier-biotech-and-gsk-enter-global-exclusive-licensing-agreement-for-small-interfering-rna-therapeutics-302695615.html

en | CH0038389992 | FRONTIER | boerse | 68725567 |